Get started
FISHER + PAYKEL HEALTH.FISHER + PAYKEL HEALTH.FISHER + PAYKEL HEALTH.

FISHER + PAYKEL HEALTH.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

FPLB chart


Full chart

FPLB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.31 B‬ EUR
Dividend yield (indicated)
1.15%
Price to earnings Ratio (TTM)
56.2
Basic EPS (TTM)
0.3 EUR
Net income (FY)
‪197.97 M‬ EUR
Revenue (FY)
‪1.06 B‬ EUR
Shares float
‪555.72 M‬
Beta (1Y)
1.19

Employees


Employees (FY)
‪7.54 K‬
Change (1Y)
+394 +5.52%
Revenue / Employee (1Y)
‪140.94 K‬ EUR
Net income / Employee (1Y)
‪26.27 K‬ EUR

About FISHER & PAYKEL HEALTHCARE CORP NPV


Sector
Health Technology
Industry
Medical Specialties
CEO
Lewis George Gradon
Website
fphcare.com
Headquarters
Auckland
Founded
1934
ISIN
NZFAPE0001S2
FIGI
BBG000CPR171
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

FPLB news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as FPLB.

Frequently Asked Questions


The current price of FPLB is 18.6 EUR — it has decreased by −1.06% in the past 24 hours. Watch FISHER + PAYKEL HEALTH. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange FISHER + PAYKEL HEALTH. stocks are traded under the ticker FPLB.
FPLB stock has fallen by −1.06% compared to the previous week, the month change is a −1.06% fall, over the last year FISHER + PAYKEL HEALTH. has showed a 9.41% increase.
We've gathered analysts' opinions on FISHER + PAYKEL HEALTH. future price: according to them, FPLB price has a max estimate of 23.33 EUR and a min estimate of 14.55 EUR. Watch FPLB chart and read a more detailed FISHER + PAYKEL HEALTH. stock forecast: see what analysts think of FISHER + PAYKEL HEALTH. and suggest that you do with its stocks.
FPLB reached its all-time high on Nov 29, 2024 with the price of 21.8 EUR, and its all-time low was 10.2 EUR and was reached on Oct 13, 2022. View more price dynamics on FPLB chart.
See other stocks reaching their highest and lowest prices.
FPLB stock is 1.08% volatile and has beta coefficient of 1.19. Track FISHER + PAYKEL HEALTH. stock price on the chart and check out the list of the most volatile stocks — is FISHER + PAYKEL HEALTH. there?
Today FISHER + PAYKEL HEALTH. has the market capitalization of ‪11.31 B‬, it has decreased by −4.44% over the last week.
Yes, you can track FISHER + PAYKEL HEALTH. financials in yearly and quarterly reports right on TradingView.
FISHER + PAYKEL HEALTH. is going to release the next earnings report on Nov 26, 2025. Keep track of upcoming events with our Earnings Calendar.
FPLB earnings for the last half-year are 0.20 EUR per share, whereas the estimation was 0.19 EUR, resulting in a 6.69% surprise. The estimated earnings for the next half-year are 0.19 EUR per share. See more details about FISHER + PAYKEL HEALTH. earnings.
FISHER + PAYKEL HEALTH. revenue for the last half-year amounts to ‪561.48 M‬ EUR, despite the estimated figure of ‪559.27 M‬ EUR. In the next half-year revenue is expected to reach ‪629.18 M‬ EUR.
FPLB net income for the last half-year is ‪117.56 M‬ EUR, while the previous report showed ‪87.29 M‬ EUR of net income which accounts for 34.68% change. Track more FISHER + PAYKEL HEALTH. financial stats to get the full picture.
FISHER + PAYKEL HEALTH. dividend yield was 1.49% in 2024, and payout ratio reached 77.62%. The year before the numbers were 1.90% and 214.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 14, 2025, the company has ‪7.54 K‬ employees. See our rating of the largest employees — is FISHER + PAYKEL HEALTH. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FISHER + PAYKEL HEALTH. EBITDA is ‪342.20 M‬ EUR, and current EBITDA margin is 32.22%. See more stats in FISHER + PAYKEL HEALTH. financial statements.
Like other stocks, FPLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FISHER + PAYKEL HEALTH. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FISHER + PAYKEL HEALTH. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FISHER + PAYKEL HEALTH. stock shows the buy signal. See more of FISHER + PAYKEL HEALTH. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.